Are you Dr. Peppercorn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 77 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4996Fax+1 919-843-5515
Summary
- Dr. Amanda Peppercorn, MD is an infectious disease specialist in Chapel Hill, North Carolina. She is currently licensed to practice medicine in North Carolina and Massachusetts.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2002 - 2005- Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2001
Harvard Medical SchoolClass of 1998
Certifications & Licensure
MA State Medical License 2001 - 2027
NC State Medical License 2005 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Start of enrollment: 2006 May 01
Publications & Presentations
PubMed
- Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study.Jennifer Moore, Alicia Aylott, Wen-Hung Chen, Jerzy Daniluk, Ian A Hawes
Mabs. 2025-12-01 - Pharmacokinetics of the Monoclonal Antibody, Sotrovimab, in Healthy Participants Following IM Administration at Different Injection Sites.Asma El-Zailik, Jennifer Sager, Yasmin Sánchez-Pearson, Sergio Parra, Jennifer Moore
Clinical Pharmacology and Therapeutics. 2024-12-12 - 1 citationsInhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.Valerie J Ludbrook, David C Budd, Katie Thorn, Debra Tompson, Bartholomew J Votta
Dermatology and Therapy. 2024-02-01
Press Mentions
'Like Somebody Gave Me a Happy Pill:' Monoclonal Antibodies Are Helping the Americans Most at Risk for COVID-19April 17th, 2021- To Get Ahead of Variants, Covid-19 Drug Makers Use Evolutionary Biology as a GuideFebruary 20th, 2021
